Efficacy and safety of degludec versus Glargine in Type 2 Diabetes

S.P. Marso, D.K. Mcguire, B. Zinman, N.R. Poulter, S.S. Emerson, T.R. Pieber, R.E. Pratley, P.-M. Haahr, M. Lange, K. Brown-Frandsen, A. Moses, S. Skibsted, K. Kvist, J.B. Buse

Research output: Contribution to journalArticle

221 Citations (Scopus)
Original languageEnglish
Pages (from-to)723-732
Number of pages10
JournalNew England Journal of Medicine
Volume377
Issue number8
DOIs
Publication statusPublished - 2017
Externally publishedYes

Cite this

Marso, S. P., Mcguire, D. K., Zinman, B., Poulter, N. R., Emerson, S. S., Pieber, T. R., ... Buse, J. B. (2017). Efficacy and safety of degludec versus Glargine in Type 2 Diabetes. New England Journal of Medicine, 377(8), 723-732. https://doi.org/10.1056/NEJMoa1615692

Efficacy and safety of degludec versus Glargine in Type 2 Diabetes. / Marso, S.P.; Mcguire, D.K.; Zinman, B.; Poulter, N.R.; Emerson, S.S.; Pieber, T.R.; Pratley, R.E.; Haahr, P.-M.; Lange, M.; Brown-Frandsen, K.; Moses, A.; Skibsted, S.; Kvist, K.; Buse, J.B.

In: New England Journal of Medicine, Vol. 377, No. 8, 2017, p. 723-732.

Research output: Contribution to journalArticle

Marso, SP, Mcguire, DK, Zinman, B, Poulter, NR, Emerson, SS, Pieber, TR, Pratley, RE, Haahr, P-M, Lange, M, Brown-Frandsen, K, Moses, A, Skibsted, S, Kvist, K & Buse, JB 2017, 'Efficacy and safety of degludec versus Glargine in Type 2 Diabetes', New England Journal of Medicine, vol. 377, no. 8, pp. 723-732. https://doi.org/10.1056/NEJMoa1615692
Marso SP, Mcguire DK, Zinman B, Poulter NR, Emerson SS, Pieber TR et al. Efficacy and safety of degludec versus Glargine in Type 2 Diabetes. New England Journal of Medicine. 2017;377(8):723-732. https://doi.org/10.1056/NEJMoa1615692
Marso, S.P. ; Mcguire, D.K. ; Zinman, B. ; Poulter, N.R. ; Emerson, S.S. ; Pieber, T.R. ; Pratley, R.E. ; Haahr, P.-M. ; Lange, M. ; Brown-Frandsen, K. ; Moses, A. ; Skibsted, S. ; Kvist, K. ; Buse, J.B. / Efficacy and safety of degludec versus Glargine in Type 2 Diabetes. In: New England Journal of Medicine. 2017 ; Vol. 377, No. 8. pp. 723-732.
@article{d3723cc5eb81488184ccfbb044a218e2,
title = "Efficacy and safety of degludec versus Glargine in Type 2 Diabetes",
author = "S.P. Marso and D.K. Mcguire and B. Zinman and N.R. Poulter and S.S. Emerson and T.R. Pieber and R.E. Pratley and P.-M. Haahr and M. Lange and K. Brown-Frandsen and A. Moses and S. Skibsted and K. Kvist and J.B. Buse",
note = "Cited By :20 Export Date: 5 March 2018",
year = "2017",
doi = "10.1056/NEJMoa1615692",
language = "English",
volume = "377",
pages = "723--732",
journal = "New England Journal of Medicine",
issn = "0028-4793",
publisher = "Massachussetts Medical Society",
number = "8",

}

TY - JOUR

T1 - Efficacy and safety of degludec versus Glargine in Type 2 Diabetes

AU - Marso, S.P.

AU - Mcguire, D.K.

AU - Zinman, B.

AU - Poulter, N.R.

AU - Emerson, S.S.

AU - Pieber, T.R.

AU - Pratley, R.E.

AU - Haahr, P.-M.

AU - Lange, M.

AU - Brown-Frandsen, K.

AU - Moses, A.

AU - Skibsted, S.

AU - Kvist, K.

AU - Buse, J.B.

N1 - Cited By :20 Export Date: 5 March 2018

PY - 2017

Y1 - 2017

U2 - 10.1056/NEJMoa1615692

DO - 10.1056/NEJMoa1615692

M3 - Article

VL - 377

SP - 723

EP - 732

JO - New England Journal of Medicine

JF - New England Journal of Medicine

SN - 0028-4793

IS - 8

ER -